Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of cGMP

By Ishibashi Yuji  

Clinical and Experimental Medicine, Vol. 11, Iss. 2, 2011-06 ,pp. : 131-135

Springer Publishing Company

Access to resources Recommend Favorite

Antagonism of IL-4 Signaling by a Phosphodiesterase-4 Inhibitor, Rolipram, in Human T Cells

By  

International Archives of Allergy and Immunology, Vol. 143, Iss. 3, 2007-02 ,pp. : 216-224

Karger

Access to resources Recommend Favorite

Relaxation Effect of Phosphodiesterase-5 Inhibitor on the Animal Bladder and Prostatic Urethra: in vitro and in vivo Study

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 231-235

Karger

Access to resources Recommend Favorite

Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells

By Monteagudo Silvia   Pérez-Martínez Francisco C   Pérez-Carrión María D   Guerra Javier   Merino Sonia   Sánchez-Verdú María Prado   Ceña Valentín  

Nanomedicine, Vol. 7, Iss. 4, 2012-04 ,pp. : 493-506

Future Medicine

Access to resources Recommend Favorite

In vitro and in vivo Effects of Vardenafil (a PDE-5 Inhibitor) on Corpus Cavernosal Smooth Muscle Relaxation in Diabetic Rabbits

By  

Urologia Internationalis, Vol. 82, Iss. 1, 2009-01 ,pp. : 101-107

Karger

Access to resources Recommend Favorite